Framework supply of inhaled beta-2 agonists
Original notice title
Malta – Toxins – CT2124/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF INHALED LONG-ACTING BETA 2 AGONIST FOR CHILDREN BETWEEN 4 AND 12 YEARS OF AGE (SALMETEROL OR FORMOTEROL)
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Department of Contracts
- Country
- Malta
- CPV
- 33693100 - Toxins
- Deadline
- Jul 31, 2026
- Estimated value
- EUR 1.6M
AI tender analysis
Tenderwize prepares an AI analysis of this tender based on the TED notice and procurement documents: scope of work, key requirements, eligibility criteria, risks and questions for the buyer. The analysis is generated when the tender is opened.
Buyer
Location
Floriana, MLT
Website
Buyer profile
Identifier
MT25645419
Activity
General public services
Lots (1)
LOT-0001
CT2124/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF INHALED LONG-ACTING BETA 2 AGONIST FOR CHILDREN BETWEEN 4 AND 12 YEARS OF AGE (SALMETEROL OR FORMOTEROL)
CT2124/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF INHALED LONG-ACTING BETA 2 AGONIST FOR CHILDREN BETWEEN 4 AND 12 YEARS OF AGE (SALMETEROL OR FORMOTEROL)
EUR 1.6M
Estimated value
Location
Category
Award details
CT2124/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF INHALED LONG-ACTING BETA 2 AGONIST FOR CHILDREN BETWEEN 4 AND 12 YEARS OF AGE (SALMETEROL OR FORMOTEROL)
Procurement Details
- Publication date
- 07 Jul 2026
- Languages
- English
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 468247-2026
Documents (2)
Similar tenders
Poland – Pharmaceutical products – Dostawa produktów leczniczych refundowanych w ramach programów lekowych (ZP-126/2026)
Poland – Pharmaceutical products – produkty lecznicze w 309 pakietach dla potrzeb Apteki Szpitalnej Wojewódzkiego Szpitala Zespolonego w Elblągu
Poland – Antineoplastic and immunomodulating agents – Dostawy produktów leczniczych stosowanych w programach lekowych i chemioterapii
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications